Register entry
- Registered sites
- 0
- Active NDC listings
- 21
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
2121 active NDC listings: 21 human prescription drug. By marketing category: ANDA 21.
| Dosage form | NDCs |
|---|---|
| capsule | 10 |
| tablet | 6 |
| capsule, delayed release | 2 |
| tablet, film coated | 2 |
| tablet, film coated, extended release | 1 |
| Route | NDCs |
|---|---|
| oral | 22 |
| Labeller name on the listing | NDCs |
|---|---|
| civicascript llc | 15 |
| civicascript, llc | 6 |
Catalogue
Marketed products
21| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Abiraterone | Abiraterone acetate | tablet, oral | 82249-010ANDA |
| Abirtega | Abiraterone acetate | tablet, oral, oral | 82249-011ANDA |
| Capecitabine | Capecitabine | tablet, film coated, oral | 82249-207ANDA |
| Capecitabine | Capecitabine | tablet, film coated, oral | 82249-210ANDA |
| Dalfampridine | Dalfampridine | tablet, film coated, extended release, oral | 82249-702ANDA |
| Dimethyl fumarate | Dimethyl fumarate | capsule, delayed release, oral | 82249-745ANDA |
| Dimethyl fumarate | Dimethyl fumarate | capsule, delayed release, oral | 82249-747ANDA |
| Droxidopa | Droxidopa | capsule, oral | 82249-551ANDA |
| Droxidopa | Droxidopa | capsule, oral | 82249-552ANDA |
| Droxidopa | Droxidopa | capsule, oral | 82249-554ANDA |
| Fingolimod | Fingolimod | capsule, oral | 82249-385ANDA |
| Temozolomide | Temozolomide | capsule, oral | 82249-404ANDA |
| Temozolomide | Temozolomide | capsule, oral | 82249-406ANDA |
| Temozolomide | Temozolomide | capsule, oral | 82249-408ANDA |
| Temozolomide | Temozolomide | capsule, oral | 82249-410ANDA |
| Temozolomide | Temozolomide | capsule, oral | 82249-412ANDA |
| Temozolomide | Temozolomide | capsule, oral | 82249-414ANDA |
| Yulithira | Everolimus | tablet, oral | 82249-610ANDA |
| Yulithira | Everolimus | tablet, oral | 82249-611ANDA |
| Yulithira | Everolimus | tablet, oral | 82249-612ANDA |
| Yulithira | Everolimus | tablet, oral | 82249-613ANDA |
Compare
Other companies listing temozolomide
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Hetero Labs Limited8 sites · 167 NDC
- ACCORD HEALTHCARE LIMITED2 sites · 242 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Amneal Ireland Limited1 site · 513 NDC
- Excella GmbH & Co. KG1 site · 73 NDC
- Formosa Laboratories, Inc.1 site · 33 NDC
- Hubei Haosun Pharmaceutical Co., Ltd.1 site · 11 NDC
- ASCEND Therapeutics US, LLC0 sites · 350 NDC
- Merck Sharp & Dohme Corp.0 sites · 121 NDC
Enquiry
Common questions
- Is CivicaScript, LLC FDA approved?
- CivicaScript, LLC holds no registered establishment of its own; 21 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does CivicaScript, LLC make?
- 21 products are listed under CivicaScript, LLC in the openFDA NDC Directory, most often as capsule; tablet; capsule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.